Work

Use of other disease-modifying therapies after or between alemtuzumab treatments: pooled results from the CAMMS223, and CARE-MS I and II studies over 8 years

Year: 2019

Type: article

Source: Document Server@UHasselt (UHasselt)

Authors: Vermersch, P., Baker, M., Bass, A. D., Berkovich, R., Comi, G., Eichau, S., Graves, D., Hunter, S. F., Ionete, C., Limmroth, V., Meuth, S. G., Naismith, R. T., Sharrack, B., Subei, A., Daizadeh, N., Choudhry, Z., Van Wijmeersch, Bart

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2972705973

FWCI:

Cites:

Cited by:

Related to: 10